Humanwell Healthcare (600079.SH) has received the drug registration certificate for the lorazepam tablets.

15/01/2025

GMT Eight

Humanwell Healthcare (600079.SH) announced that its holding subsidiary, Yichang Renfu Pharmaceutical Co., Ltd., has recently received the Drug Registration Certificate issued by the National Medical Products Administration for its tablet of Mirtazapine Maleate. Mirtazapine Maleate is indicated for sleep disorders, insomnia, especially for those who have difficulty falling asleep, and for preoperative or diagnostic procedures.

Suzhou Kingswood Education Technology (300192.SZ) plans to distribute 1 yuan per 10 shares for the first three quarters. Ex-dividend and ex-dividend on January 22nd.

Tongxing Environmental Protection Technology (003027.SZ) expects a net profit of 32.71 million to 40.83 million yuan for the year 2024, an increase of 28.05% to 59.86%.

Contact: contact@gmteight.com

Humanwell Healthcare (600079.SH) has received the drug registration certificate for the lorazepam tablets.

RECOMMEND

US Stock Market Move | Intuitive Surgical, Inc. (ISRG.US) rose more than 6.4%, with its stock price briefly reaching a new all-time high.

US Stock Market Move | NVIDIA Corporation holds the concept of strong offensive inventory, and Nano X Imaging (NNOX.US) surged by more than 21%.

US Stock Market Move | Goldman Sachs Group, Inc. has rated the company as a "buy" with Micron Technology, Inc. (MU.US) rising over 6%.